Taysha Gene Therapies, Inc. Contracts & Agreements
38 Contracts & Agreements
- Business Finance (15 contracts)
- Business Operations (4)
- Human Resources (8)
- Intellectual Property (3)
- Real Estate (2)
- Uncategorized (6)
- Underwriting Agreement by and between Taysha Gene Therapies, Inc. and Jefferies LLC and Goldman Sachs & Co. LLC, dated June 26, 2024 (Filed With SEC on June 26, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on June 26, 2024)
- Taysha Gene Therapies, Inc. 2023 Inducement Plan (Filed With SEC on December 20, 2023)
- Form of RSU Award Grant Notice and RSU Award Agreement under the 2023 Inducement Plan (Filed With SEC on December 20, 2023)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2023 Inducement Plan (Filed With SEC on December 20, 2023)
- Loan and Security Agreement, dated November 13, 2023 by and among the Company (Filed With SEC on November 14, 2023)
- Amended and Restated Non-employee director compensation policy (Filed With SEC on August 14, 2023)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on August 14, 2023)
- Form of Securities Purchase Agreement, dated August 14, 2023, by and among Taysha Gene Therapies, Inc. and the Purchasers (Filed With SEC on August 14, 2023)
- Option Agreement, by and between the Company and Astellas, dated October 21, 2022 (Filed With SEC on October 31, 2022)
- Securities Purchase Agreement, by and between the Company and Astellas, dated October 21, 2022 (Filed With SEC on October 31, 2022)
- Registration Rights Agreement, by and between the Company and Astellas, dated October 21, 2022 (Filed With SEC on October 31, 2022)
- Underwriting Agreement by and between Taysha Gene Therapies, Inc. and Goldman Sachs & Co. LLC, dated October 26, 2022 (Filed With SEC on October 27, 2022)
- First Amendment to Lease Agreement, dated December 14, 2021, by and between Pegasus Park, LLC and the Company (Filed With SEC on March 31, 2022)
- Amendment No. 1 to Sales Agreement, dated March 30, 2022, by and among the Company, Goldman Sachs & Co. LLC, SVB Securities LLC and Wells Fargo Securities, LLC (Filed With SEC on March 31, 2022)
- Lease Agreement, dated January 11, 2021, by and between Pegasus Place, LLC and the Company (Filed With SEC on August 16, 2021)
- Loan and Security Agreement, dated August 12, 2021, by and among the Company, the lenders party thereto from time to time and Silicon Valley Bank, as administrative agent and... (Filed With SEC on August 16, 2021)
- Description of the Companys Common Stock (Filed With SEC on March 3, 2021)
- License Agreement, by and between the Company and Abeona Therapeutics Inc., dated as of October 29, 2020 (Filed With SEC on March 3, 2021)
- Amended and Restated Offer Letter, effective as of September 24, 2020, by and between the Company and Kamran Alam (Filed With SEC on March 3, 2021)
- Amended and Restated Offer Letter, effective as of September 24, 2020, by and between the Company and Suyash Prasad (Filed With SEC on March 3, 2021)
- Amended and Restated Executive Employment Agreement, effective as of September 24, 2020, by and between the Company and RA Session II (Filed With SEC on November 12, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 17, 2020)
- 2020 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (as amended) (Filed With SEC on September 17, 2020)
- 2020 Stock Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement (Filed With SEC on September 17, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on September 17, 2020)
- Form of Indemnification Agreement with Executive Officers and Directors (Filed With SEC on September 17, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on September 17, 2020)
- Change in Control Severance Plan and Form of Participation Agreement (Filed With SEC on September 17, 2020)
- Form of Amended and Restated Offer Letter, to be entered into by and between the Registrant and the Registrants Executive Officers (Filed With SEC on September 17, 2020)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated July 2, 2020 (Filed With SEC on September 2, 2020)
- Research, Collaboration & License Agreement, by and between the Registrant and The Board of Regents of the University of Texas System on behalf of The University of Texas... (Filed With SEC on September 2, 2020)
- Amendment to Research, Collaboration & License Agreement, by and between the Registrant and The Board of Regents of the University of Texas System on behalf of The University of... (Filed With SEC on September 2, 2020)
- License Agreement, by and between the Registrant and Queens University at Kingston, dated as of February 21, 2020 (Filed With SEC on September 2, 2020)
- License Agreement, by and between the Registrant and Abeona Therapeutics Inc., dated as of August 14, 2020 (Filed With SEC on September 2, 2020)
- 2020 Equity Incentive Plan and Forms of Option Grant Notice and Agreement, Exercise Notice, Early Exercise Notice and Restricted Stock Award Notice (Filed With SEC on September 2, 2020)
- Executive Employment Agreement, by and between the Registrant and RA Session II, dated as of April 1, 2020 (Filed With SEC on September 2, 2020)
